Ten Year Experience of Radioiodine Dosimetry: is it Useful in the Management of Metastatic Differentiated Thyroid Cancer?

MLA

Sun, F., et al. “Ten Year Experience of Radioiodine Dosimetry: Is It Useful in the Management of Metastatic Differentiated Thyroid Cancer?” Clinical Oncology (Royal College of Radiologists (Great Britain)), vol. 29, no. 5, May 2017, pp. 310–15. EBSCOhost, https://doi.org/10.1016/j.clon.2017.01.002.

APA

Sun, F., Gerrard, G. E., Roberts, J. K., Telford, T., Namini, S., Waller, M., Flux, G., & Gill, V. M. (2017). Ten Year Experience of Radioiodine Dosimetry: is it Useful in the Management of Metastatic Differentiated Thyroid Cancer? Clinical Oncology (Royal College of Radiologists (Great Britain)), 29(5), 310–315. https://doi.org/10.1016/j.clon.2017.01.002

Chicago

Sun, F, G E Gerrard, J K Roberts, T Telford, S Namini, M Waller, G Flux, and V M Gill. 2017. “Ten Year Experience of Radioiodine Dosimetry: Is It Useful in the Management of Metastatic Differentiated Thyroid Cancer?” Clinical Oncology (Royal College of Radiologists (Great Britain)) 29 (5): 310–15. doi:10.1016/j.clon.2017.01.002.